| (210) | Number of the EPO application | 16736718 |
| (220) | Filing date of the EPO application | 2016.06.28 |
| (80) | EPO patent specification publication (B) | EPB nr. 47/2020, 2020.11.18 |
| (110) | EPO patent number | 3313884 |
| (11) | Number of the document | MD 3313884 T9 |
| (21) | Number of the application | e 2018 0449 |
| (71) | Name(s) of applicant(s), code of the country | ImmunoGen, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | KOVTUN Yelena, US;
TAVARES Daniel, US;
RUI Lingyun, US;
CHITTENDEN Thomas, US; |
| (73) | Name(s) of owner(s), code of the country | IMMUNOGEN Inc., US; |
| (54) | Title of the invention | Anti-cd123 antibodies and conjugates and derivatives thereof |
| (13) | Kind-of-document code | T9 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); A61K 39/395 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.06.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.04.30 |
| (30) | Priority | 201562186161 P, 2015.06.29, US; 201662338203 P, 2016.05.18, US; 201662346730 P, 2016.06.07, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2016/039797, 2016.06.28 |
| (87) | International publication | WO 2017/004026, 2017.01.05 |